3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
4
Withdrawn
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
6
Other hematologic neoplasm
4
Plasma cell
1
Myeloid
1
Genitourinary
1
Conditions
Myelodysplastic Syndromes
57
Leukemia, Myeloid, Acute
53
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
34
Precursor Cell Lymphoblastic Leukemia-Lymphoma
29
Myeloproliferative Disorders
24
Leukemia
24
Primary Myelofibrosis
22
Leukemia, Myelomonocytic, Chronic
19
Lymphoma, Non-Hodgkin
18
Leukemia, Lymphocytic, Chronic, B-Cell
18
Hodgkin Disease
16
Lymphoma, Follicular
15
Multiple Myeloma
14
Lymphoma, Mantle-Cell
14
Lymphoma, B-Cell, Marginal Zone
14
Leukemia, Myeloid, Chronic-Phase
14
Burkitt Lymphoma
14
Polycythemia Vera
13
Lymphoma, Large B-Cell, Diffuse
12
Lymphoma
12
Leukemia, Myeloid, Accelerated Phase
12
Lymphoma, Large-Cell, Immunoblastic
11
Hematologic Neoplasms
11
Congenital Abnormalities
11
Blast Crisis
11
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
10
Sezary Syndrome
9
Recurrence
9
Pdgfra-Associated Chronic Eosinophilic Leukemia
9
Mycosis Fungoides
9
Interventions
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
COVID-19
×
Myeloid
×
Clear all
NCT04953312
2026-03-12
CALPRO
Assistance Publique - Hôpitaux de Paris
Phase NA
Withdrawn